K-7174 dihydrochloride is primarily researched for its potential in treating inflammatory diseases due to its ability to inhibit specific signaling pathways involved in inflammation. It has shown promise in preclinical studies for conditions like rheumatoid arthritis and inflammatory bowel disease by reducing the production of pro-inflammatory cytokines. Additionally, it is being explored for its role in cancer therapy, as it may interfere with tumor growth and metastasis by modulating cell adhesion and migration processes. Its application in cardiovascular diseases is also under investigation, particularly in preventing vascular inflammation and atherosclerosis. Further research is ongoing to validate its efficacy and safety in these therapeutic areas.